Rolling Out4h
Breakthrough diabetes drug slashes dementia risk by 35%
New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...
emjreviews.com13h
SGLT2 Inhibitors Improve Kidney Health in Asian Adults with Type 2 Diabetes
SGLT2 inhibitors significantly improves kidney health in a diverse group of Asian adults with Type 2 diabetes, study finds.
News Medical2d
Dapagliflozin plus calorie restriction boosts remission rates in adults with type 2 diabetes and obesity
Findings indicate that dapagliflozin and calorie restriction together improve weight loss and metabolic health, increasing ...
SGLT-2 drug plus moderate calorie restriction achieves higher diabetes remission, clinical trial finds
Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor ...
Medpage Today on MSN4d
No Clear Winner in SGLT2 Showdown for Cardiovascular Disease
Taken at face value, the results would suggest that the three SGLT2 inhibitors are "virtually identical," according to ...
Weight-loss drugs: Study involving 2 million people identifies potential benefits beyond obesity treatment and other risks
The study in Nature Medicine explores the potential wider benefits and risks of diabetes drugs GLP-1 receptor agonists.
Healio13d
Obesity medications can tackle metabolic cardiorenal disease
The effects of SGLT2 inhibitors on the kidney to prevent progression of chronic kidney disease, congestive heart failure, ...
Medscape15d
Cost–Effectiveness of Angiotensin-converting Enzyme Inhibitors in Nondiabetic Advanced Renal Disease
Objective: To determine the cost–effectiveness of ACE inhibitor therapy in nondiabetic proteinuric patients with advanced renal disease in Germany. Methods: Two strategies were compared ...